HEADER PROTEIN BINDING 26-FEB-12 4AKN TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH TBUTYL-PHENYL-AMINO- TITLE 2 DIMETHYL-OXAZOLYL-QUINOLINE-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 67-200; COMPND 5 SYNONYM: O27.1.1, REALLY INTERESTING NEW GENE 3 PROTEIN HUMAN BRD2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN BINDING, INHIBITOR, HISTONE, EPIGENETIC READER EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG,Y.LAMOTTE,F.DONCHE,A.BOUILLOT,O.MIRGUET REVDAT 3 15-MAY-19 4AKN 1 REMARK REVDAT 2 14-NOV-12 4AKN 1 SEQADV REVDAT 1 04-JUL-12 4AKN 0 JRNL AUTH J.SEAL,Y.LAMOTTE,F.DONCHE,A.BOUILLOT,O.MIRGUET,F.GELLIBERT, JRNL AUTH 2 E.NICODEME,G.KRYSA,J.KIRILOVSKY,S.BEINKE,S.MCCLEARY,I.RIOJA, JRNL AUTH 3 P.BAMBOROUGH,C.CHUNG,L.GORDON,T.LEWIS,A.L.WALKER,L.CUTLER, JRNL AUTH 4 D.LUGO,D.M.WILSON,J.WITHERINGTON,K.LEE,R.K.PRINJHA JRNL TITL IDENTIFICATION OF A NOVEL SERIES OF BET FAMILY BROMODOMAIN JRNL TITL 2 INHIBITORS: BINDING MODE AND PROFILE OF I-BET151 JRNL TITL 3 (GSK1210151A). JRNL REF BIOORG.MED.CHEM.LETT. V. 22 2968 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22437115 JRNL DOI 10.1016/J.BMCL.2012.02.041 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 36320 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1517 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2485 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.98 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.2370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2755 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.91000 REMARK 3 B22 (A**2) : -0.48000 REMARK 3 B33 (A**2) : -0.55000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.81000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.117 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.110 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.070 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.360 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3037 ; 0.005 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2038 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4138 ; 0.870 ; 1.941 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4991 ; 0.769 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 353 ; 3.832 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 145 ;35.605 ;25.103 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 548 ;11.428 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;22.839 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 425 ; 0.049 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3329 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 607 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 75 A 186 REMARK 3 ORIGIN FOR THE GROUP (A): 16.2839 6.7543 2.0946 REMARK 3 T TENSOR REMARK 3 T11: 0.0320 T22: 0.0430 REMARK 3 T33: 0.0769 T12: 0.0126 REMARK 3 T13: 0.0209 T23: 0.0053 REMARK 3 L TENSOR REMARK 3 L11: 0.9135 L22: 0.7779 REMARK 3 L33: 1.5245 L12: -0.5039 REMARK 3 L13: -0.2541 L23: 0.1117 REMARK 3 S TENSOR REMARK 3 S11: -0.0489 S12: -0.0319 S13: -0.0811 REMARK 3 S21: 0.0399 S22: 0.0047 S23: 0.0866 REMARK 3 S31: -0.0098 S32: -0.1170 S33: 0.0442 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 73 B 182 REMARK 3 ORIGIN FOR THE GROUP (A): 34.7250 8.9388 10.8964 REMARK 3 T TENSOR REMARK 3 T11: 0.0551 T22: 0.0235 REMARK 3 T33: 0.0725 T12: 0.0146 REMARK 3 T13: -0.0226 T23: -0.0038 REMARK 3 L TENSOR REMARK 3 L11: 0.4800 L22: 1.2893 REMARK 3 L33: 1.5419 L12: -0.3330 REMARK 3 L13: -0.1206 L23: 0.1452 REMARK 3 S TENSOR REMARK 3 S11: -0.0220 S12: -0.0465 S13: 0.0024 REMARK 3 S21: 0.1110 S22: 0.0738 S23: -0.0662 REMARK 3 S31: -0.0231 S32: 0.0527 S33: -0.0518 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 76 C 182 REMARK 3 ORIGIN FOR THE GROUP (A): -1.5885 18.8862 23.5680 REMARK 3 T TENSOR REMARK 3 T11: 0.0176 T22: 0.1231 REMARK 3 T33: 0.0260 T12: 0.0065 REMARK 3 T13: 0.0040 T23: 0.0118 REMARK 3 L TENSOR REMARK 3 L11: 0.3108 L22: 1.7737 REMARK 3 L33: 2.7301 L12: 0.0185 REMARK 3 L13: 0.7932 L23: -0.3688 REMARK 3 S TENSOR REMARK 3 S11: -0.0246 S12: 0.0462 S13: 0.0122 REMARK 3 S21: -0.1469 S22: 0.1175 S23: 0.0021 REMARK 3 S31: -0.0410 S32: 0.0908 S33: -0.0929 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED REMARK 4 REMARK 4 4AKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1290051483. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37838 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-26 % PEG3350, 0.2 M (NH4)2SO4, 100 REMARK 280 MM HEPES PH 7.0. AT 20C, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.15700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.86500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.15700 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.86500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -5.14521 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 67.79604 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 SER A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 SER A 56 REMARK 465 SER A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 VAL A 60 REMARK 465 PRO A 61 REMARK 465 ARG A 62 REMARK 465 GLY A 63 REMARK 465 SER A 64 REMARK 465 HIS A 65 REMARK 465 MET A 66 REMARK 465 SER A 67 REMARK 465 ASN A 68 REMARK 465 PRO A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 ARG A 74 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 ASN A 193 REMARK 465 SER A 194 REMARK 465 HIS A 195 REMARK 465 LYS A 196 REMARK 465 LYS A 197 REMARK 465 GLY A 198 REMARK 465 ALA A 199 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 SER B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 SER B 56 REMARK 465 SER B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 VAL B 60 REMARK 465 PRO B 61 REMARK 465 ARG B 62 REMARK 465 GLY B 63 REMARK 465 SER B 64 REMARK 465 HIS B 65 REMARK 465 MET B 66 REMARK 465 SER B 67 REMARK 465 ASN B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 PRO B 72 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 ASN B 193 REMARK 465 SER B 194 REMARK 465 HIS B 195 REMARK 465 LYS B 196 REMARK 465 LYS B 197 REMARK 465 GLY B 198 REMARK 465 ALA B 199 REMARK 465 GLY C 47 REMARK 465 SER C 48 REMARK 465 SER C 49 REMARK 465 HIS C 50 REMARK 465 HIS C 51 REMARK 465 HIS C 52 REMARK 465 HIS C 53 REMARK 465 HIS C 54 REMARK 465 HIS C 55 REMARK 465 SER C 56 REMARK 465 SER C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 VAL C 60 REMARK 465 PRO C 61 REMARK 465 ARG C 62 REMARK 465 GLY C 63 REMARK 465 SER C 64 REMARK 465 HIS C 65 REMARK 465 MET C 66 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 PRO C 69 REMARK 465 LYS C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 ASN C 193 REMARK 465 SER C 194 REMARK 465 HIS C 195 REMARK 465 LYS C 196 REMARK 465 LYS C 197 REMARK 465 GLY C 198 REMARK 465 ALA C 199 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN C 182 CG CD OE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET A 123 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 123 CG - SD - CE ANGL. DEV. = -11.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2080 DISTANCE = 6.66 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S5B A 1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1189 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1190 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S5B B 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS C 1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1184 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OFHUMAN REMARK 900 BRD2 REMARK 900 RELATED ID: 2YDW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GW841819X REMARK 900 RELATED ID: 2YEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GSK525762 (IBET) REMARK 900 RELATED ID: 4A9E RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9F RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1- METHYLPYRROLIDIN-2-ONE REMARK 900 RELATED ID: 4A9H RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2- METHYL-1,2,3,4- REMARK 900 TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE REMARK 900 RELATED ID: 4A9I RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9J RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4- HYDROXYPHENYL) REMARK 900 ACETAMIDE REMARK 900 RELATED ID: 4A9M RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPENTYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9N RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPROPYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9O RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ETHYL-3 -METHYL-4- REMARK 900 PHENYL-1,2-OXAZOLE REMARK 900 RELATED ID: 4A9P RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 DIMETHYL-4-PHENYL-1,2- REMARK 900 OXAZOLE REMARK 900 RELATED ID: 4ALG RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH IBET-151 DBREF 4AKN A 67 199 UNP P25440 BRD2_HUMAN 67 200 DBREF 4AKN B 67 199 UNP P25440 BRD2_HUMAN 67 200 DBREF 4AKN C 67 199 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4AKN GLY A 47 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER A 48 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER A 49 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 50 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 51 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 52 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 53 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 54 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 55 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER A 56 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER A 57 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY A 58 UNP P25440 EXPRESSION TAG SEQADV 4AKN LEU A 59 UNP P25440 EXPRESSION TAG SEQADV 4AKN VAL A 60 UNP P25440 EXPRESSION TAG SEQADV 4AKN PRO A 61 UNP P25440 EXPRESSION TAG SEQADV 4AKN ARG A 62 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY A 63 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER A 64 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS A 65 UNP P25440 EXPRESSION TAG SEQADV 4AKN MET A 66 UNP P25440 EXPRESSION TAG SEQADV 4AKN A UNP P25440 LYS 193 DELETION SEQADV 4AKN GLY B 47 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER B 48 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER B 49 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 50 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 51 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 52 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 53 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 54 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 55 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER B 56 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER B 57 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY B 58 UNP P25440 EXPRESSION TAG SEQADV 4AKN LEU B 59 UNP P25440 EXPRESSION TAG SEQADV 4AKN VAL B 60 UNP P25440 EXPRESSION TAG SEQADV 4AKN PRO B 61 UNP P25440 EXPRESSION TAG SEQADV 4AKN ARG B 62 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY B 63 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER B 64 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS B 65 UNP P25440 EXPRESSION TAG SEQADV 4AKN MET B 66 UNP P25440 EXPRESSION TAG SEQADV 4AKN B UNP P25440 LYS 193 DELETION SEQADV 4AKN GLY C 47 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER C 48 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER C 49 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 50 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 51 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 52 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 53 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 54 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 55 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER C 56 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER C 57 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY C 58 UNP P25440 EXPRESSION TAG SEQADV 4AKN LEU C 59 UNP P25440 EXPRESSION TAG SEQADV 4AKN VAL C 60 UNP P25440 EXPRESSION TAG SEQADV 4AKN PRO C 61 UNP P25440 EXPRESSION TAG SEQADV 4AKN ARG C 62 UNP P25440 EXPRESSION TAG SEQADV 4AKN GLY C 63 UNP P25440 EXPRESSION TAG SEQADV 4AKN SER C 64 UNP P25440 EXPRESSION TAG SEQADV 4AKN HIS C 65 UNP P25440 EXPRESSION TAG SEQADV 4AKN MET C 66 UNP P25440 EXPRESSION TAG SEQADV 4AKN C UNP P25440 LYS 193 DELETION SEQRES 1 A 153 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 153 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 153 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 153 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 153 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 153 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 153 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 153 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 153 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 153 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 153 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 153 THR ILE PRO ASN SER HIS LYS LYS GLY ALA SEQRES 1 B 153 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 153 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 B 153 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 B 153 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 B 153 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 B 153 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 B 153 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 B 153 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 B 153 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 B 153 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 B 153 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 B 153 THR ILE PRO ASN SER HIS LYS LYS GLY ALA SEQRES 1 C 153 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 C 153 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 C 153 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 C 153 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 C 153 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 C 153 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 C 153 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 C 153 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 C 153 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 C 153 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 C 153 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 C 153 THR ILE PRO ASN SER HIS LYS LYS GLY ALA HET EDO A1187 4 HET S5B A1188 31 HET SO4 A1189 5 HET SO4 A1190 5 HET S5B B1184 31 HET DMS C1183 4 HET SO4 C1184 5 HETNAM EDO 1,2-ETHANEDIOL HETNAM S5B 4-[(2-TERT-BUTYLPHENYL)AMINO]-7-(3,5-DIMETHYL-1,2- HETNAM 2 S5B OXAZOL-4-YL)QUINOLINE-3-CARBOXYLIC ACID HETNAM SO4 SULFATE ION HETNAM DMS DIMETHYL SULFOXIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 4 EDO C2 H6 O2 FORMUL 5 S5B 2(C25 H25 N3 O3) FORMUL 6 SO4 3(O4 S 2-) FORMUL 9 DMS C2 H6 O S FORMUL 11 HOH *333(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 LYS A 92 1 8 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 LYS B 92 1 8 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 104 GLY B 109 1 6 HELIX 13 13 ASP B 112 ILE B 117 1 6 HELIX 14 14 ASP B 122 ASN B 132 1 11 HELIX 15 15 ALA B 137 ASN B 156 1 20 HELIX 16 16 ASP B 160 ALA B 178 1 19 HELIX 17 17 THR C 76 VAL C 85 1 10 HELIX 18 18 VAL C 85 LYS C 92 1 8 HELIX 19 19 ALA C 96 ARG C 100 5 5 HELIX 20 20 ASP C 112 ILE C 117 1 6 HELIX 21 21 ASP C 122 ASN C 132 1 11 HELIX 22 22 ALA C 137 ASN C 156 1 20 HELIX 23 23 ASP C 160 SER C 179 1 20 SITE 1 AC1 9 ASN A 146 THR A 150 TYR A 153 GLU A 170 SITE 2 AC1 9 HOH A2140 ASN B 146 THR B 150 TYR B 153 SITE 3 AC1 9 GLU B 170 SITE 1 AC2 10 TRP A 97 PRO A 98 PHE A 99 LEU A 108 SITE 2 AC2 10 LEU A 110 ASN A 156 HOH A2029 HOH A2034 SITE 3 AC2 10 HOH A2063 GLN B 94 SITE 1 AC3 4 ARG A 100 HOH A2020 HOH A2022 HOH A2141 SITE 1 AC4 4 THR A 125 ARG A 128 ARG A 129 HOH A2144 SITE 1 AC5 8 GLN A 94 TRP B 97 PHE B 99 LYS B 107 SITE 2 AC5 8 LEU B 108 ASN B 156 HOH B2022 HOH B2040 SITE 1 AC6 5 VAL C 103 ASN C 156 ILE C 162 HOH C2024 SITE 2 AC6 5 HOH C2067 SITE 1 AC7 8 ARG B 100 HOH B2014 HOH B2015 ARG C 128 SITE 2 AC7 8 ASN C 132 TYR C 134 HOH C2047 HOH C2079 CRYST1 114.314 55.730 67.991 90.00 94.34 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008748 0.000000 0.000664 0.00000 SCALE2 0.000000 0.017944 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014750 0.00000